 impair erythropoietin product mice cyclosporin recent data erythropoietin epo product defect allogen bone marrow transplant bmt patient role immunosuppress nephrotox agent cyclosporin csa renal epo product anim model mice mg/kg/d csa day thereaft epo level intact anim mice anem phenylhydrazin phz serum epo level csa-treat anim predict level refer popul normal intact anem mice csa-treat intact anim hematocrit serum epo level differ control serum epo level csa-treat anem mice control popul untreat anem mice similar degre anemia signific increas serum creatinin dose csa abl sign renal toxic histolog examin kidney therapeut dose csa product epo condit demand hormon respons subclin kidney toxic csa role pathogenesi impair epo product bmt patient erythroid engraft bmt patient